Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

FRONTERA GROUP

FRONTERA GROUP is a cross-functional blend of behaviour and creative engagement experts.
Our approach identifies the underlying drivers of decision making, to uncover how choices are made today and what it will take to change them.
Using that foundation, informs better solution design to drive engagement and improve treatment decisions.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

- PMLiVE

Springer Health+

Since 1982, Springer Health+ has delivered trusted healthcare education and communications. Medical progress is more than just science, and with people at the core of everything we do, our expertise…

View Profile

Medical communications

Springer Nature

Springer Nature

Did you know that we publish over 3,000 journals, and that over 1,000 of those are clinical science journals? Promote your approved branded drugs and medical devices to our audience…

View Profile

Advertising, Medical communications, Publishers

Streaming Well - Video For Healthcare

Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual stories and interactive experiences that connect with people.

View Profile

Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Medical communications, Medical education, Publishers, Translation services

- PMLiVE

Twelve Marketing

Twelve delivers healthcare communications that drive Change for Good. We support pharma and medtech clients with strategic marketing, behaviour-led campaigns, and purposeful PR, helping teams engage professionals and the public,…

View Profile

Creative and design, Digital communications, Public relations

- PMLiVE

Visions4Health

Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…

View Profile

Health policy and government affairs, Market access, Market research

- PMLiVE

Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that we attend each year.

View Profile

Medical communications, Medical education, Publishers

- PMLiVE

Wizzard

We are Wizzard: an independently owned, fully-integrated medical communications agency that is committed to crafting brilliant and engaging work. We work alongside you to cultivate a deep understanding of your…

View Profile

Creative and design, Medical communications, Medical education

Company Details

FRONTERA GROUP
Second Home, 68 Hanbury Street, Shoreditch, E1 5JL, United Kingdom
+44 (0) 7817 410079
Contact FRONTERA GROUP
Website

 Latest Content from PMHub 

MFN Pricing Is Moving Fast – Here’s What Matters

Press Releases | February 3, 2026 | Genesis Research Group

With GENEROUS, GUARD, and GLOBE all released since December, 185 pages of policy will materially impact U.S. drug pricing — and yes, it's a lot to digest. In a new...

ISPOR’s 2026–2027 HEOR Trends report: The Era of Evidence Judgment

Press Releases | January 27, 2026 | Genesis Research Group

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that we’re no longer being evaluated on our ability to produce data, but on...

First impressions matter: Why getting your onboarding right is key for digital engagement

Press Releases | January 20, 2026 | Graphite Digital

As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked. Seamless onboarding is the key to ensuring that HCPs not only meet regulatory standards,...

How can pharma build genuine partnerships with patient communities?

White Papers and Resources | January 19, 2026 | Amiculum

Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines development, driving better outcomes, equity...

How will AI change field training?

Press Releases | January 15, 2026 | Inizio

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

The Heart and Mouth Connection Every Woman Needs to Know

Press Releases | January 9, 2026 | Medscape Education

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Press Releases | January 7, 2026 | Inizio

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

Press Releases | January 7, 2026 | Inizio

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

Press Releases | January 6, 2026 | Medscape Education

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Five Predictions That Will Reshape Biopharma Commercialisation in 2026

White Papers and Resources | January 5, 2026 | Nmblr

Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story. It’s a rough patch. A cycle that will reverse. But...